Vera Therapeutics, Inc. Class short interest in 2025
In 2025, Vera Therapeutics, Inc. Class's disclosed short interest ran from 11.51% of shares outstanding on 15 Jan 2025 to 13.23% on 31 Dec 2025, a change of +1.72 percentage points. The year's high was 16.92% on 28 Nov 2025 and its low 9.41% on 30 Apr 2025, averaging 13.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.61 days on 14 Mar 2025. Full history: Vera Therapeutics, Inc. Class.
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 11.51% (15 Jan 2025)
- End of year
- 13.23% (31 Dec 2025)
- Change
- +1.72 pp
- High
- 16.92% (28 Nov 2025)
- Low
- 9.41% (30 Apr 2025)
- Average
- 13.12%
- Highest days to cover
- 11.61 (14 Mar 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 11.51% | 10.62 | |
| 31 Jan 2025 | 12.80% | 10.38 | |
| 14 Feb 2025 | 13.20% | 7.63 | |
| 28 Feb 2025 | 12.31% | 7.69 | results (8-K), 10-K filed |
| 14 Mar 2025 | 11.45% | 11.61 | |
| 31 Mar 2025 | 10.33% | 6.74 | |
| 15 Apr 2025 | 9.60% | 5.33 | |
| 30 Apr 2025 | 9.41% | 7.78 | |
| 15 May 2025 | 11.08% | 4.65 | results (8-K), 10-Q filed |
| 30 May 2025 | 14.03% | 7.89 | |
| 13 Jun 2025 | 14.99% | 2.15 | |
| 30 Jun 2025 | 13.82% | 5.24 | |
| 15 Jul 2025 | 12.92% | 8.91 | |
| 31 Jul 2025 | 11.86% | 8.20 | |
| 15 Aug 2025 | 12.17% | 4.96 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 13.29% | 4.37 | |
| 15 Sep 2025 | 14.66% | 5.10 | |
| 30 Sep 2025 | 15.57% | 5.75 | |
| 15 Oct 2025 | 15.29% | 9.16 | |
| 31 Oct 2025 | 14.48% | 8.26 | |
| 14 Nov 2025 | 15.58% | 4.93 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 16.92% | 7.79 | |
| 15 Dec 2025 | 14.31% | 4.05 | |
| 31 Dec 2025 | 13.23% | 7.13 |
See also: Vera Therapeutics, Inc. Class's full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.